Back to Journals » OncoTargets and Therapy » Volume 11

Effective treatment of pulmonary adenocarcinoma harboring triple EGFR mutations of L858R, T790M, and cis-C797S by osimertinib, bevacizumab, and brigatinib combination therapy: a case report

Total article views   HTML views PDF downloads Totals
14,334 Dovepress* 11,260+ 1,114 12,374
PubMed Central* 3,074 808 3,882
Totals 14,334 1,922 16,256
*Since 6 September 2018
Total mentioned Facebook Delicious Reddit Twitter Others
11 0 0 0 5 6

View citations on PubMed Central and Google Scholar